Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

Brian Hutton, Georgia Salanti, Deborah M Caldwell et al. · Annals of Internal Medicine · 2015 · 8.1K citations

Public Affairs, Health Policy, Evidence-based Practice +12

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung, Sally E. Wenzel, Jan Brożek et al. · European Respiratory Journal · 2013 · 3.9K citations · Full text

Medicine, Internal Medicine, Pediatrics +13

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Héctor Ortega, Mark C. Liu, Ian Pavord et al. · New England Journal of Medicine · 2014 · 2.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

Life Sciences, Internal Medicine, Pharmacotherapy +14

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar, Christopher E. Brightling, Beverley Hargadon et al. · New England Journal of Medicine · 2009 · 1.9K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11